Daily SPAC Update – December 16, 2024

by | Dec 16, 2024

INAQ DeSPACs to Alpha Modus (AMOD) and IVCP DeSPACs to AleAnna Energy (ANNA). MITA Extension Vote Set. RRAC Moved to OTC. FACT Separate Trading on Dec 20.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

DeSPACs
Dec 16: INAQ DeSPAC to ALPHA MODUS CORP (AMOD)
Dec 16: IVCP DeSPAC to AleAnna Energy, LLC (ANNA)

SPAC VOTE RESULTS
IVCP – SWIFTMERGE ACQUISITION CORP * Deal Approved * 1,158,556 redeemed * trust $11.21

SPAC DEAL & EXTENSION VOTES SET
MITA – Coliseum Acquisition Corp * EXTENSION VOTE SET: Dec 23, 2024 * trust $11.36

OTHER SPAC NEWS
RRAC – RIGEL RESOURCE ACQUISITION CORP * Moved to OTC Trading

SPAC NON-RELIANCE 8-K
FTII – Futuretech Ii Acquisition Corp : Non-Reliance on Previously Issued Financials

SEPARATE WARRANTS/RIGHTS
FACT on Dec 20
OACC on Dec 16

YESTERDAY’S TOP SPAC GAINERS
10.41% ~ $ 10.50 | IVCP – Swiftmerge Acquisition Corp. (Announced)
5.77% ~ $ 12.47 | PRLH – Pearl Holdings Acquisition Corp (Pre-Deal)
3.48% ~ $ 6.83 | MARX – Mars Acquisition Corp. (Announced)

YESTERDAY’S TOP SPAC LOSERS
-23.02% ~ $ 3.41 | ROCL – Roth CH Acquisition V Co. (Announced)
-17.03% ~ $ 9.50 | INAQ – Insight Acquisition Corp. (Announced)
-14.80% ~ $ 9.56 | BOCN – Blue Ocean Acquisition Corp (Announced)
-4.79% ~ $ 11.33 | GLST – Global Star Acquisition Inc. (Announced)
-3.74% ~ $ 12.60 | IPXX – Inflection Point Acquisition Corp. II (Announced)

LATEST SPAC IPO PERFORMANCE
Dec 12 |  | DRDB – Roman DBDR Acquisition Corp. II
Dec 12 |  | MLAC – Mountain Lake Acquisition Corp.
Dec 10 | $ 10.04 | JACS – Jackson Acquisition Co II
Dec 04 | $ 10.01 | SPHA – Shepherd Ave Capital Acquisition Corp
Dec 04 | $ 10.00 | TAVI – Tavia Acquisition Corp.
Nov 26 | $ 9.96 | FACT – FACT II Acquisition Corp.
Nov 20 | $ 9.94 | DYNX – Dynamix Corporation
Nov 20 | $ 9.99 | NOEM – CO2 Energy Transition Corp.

Recent Analysis

Daily SPAC Update – January 16, 2025

LATG DeSPACs to Femco Steel Technology (KBSX). Plum Acquisition III Extension Vote. RRAC and EVGR Extension Votes Set. NOEM Separate Trading on Jan 16. 

Daily SPAC Update – January 15, 2025

$150M Plum Acquisition IV and $50M Ribbon Acquisition SPAC IPOs. Aimfinity (AIMAU) and Quetta (QETA) Extensions Approved. Bowen (BOWN) + Qianzhi BioTech Deal Approved. 

Daily SPAC Update – January 14, 2025

Cohen Circle (CCIR) LOI with Ukranian Firm. BRKH DeSPACs to Blaize (BZAI). PPYA Extension Vote. Aimfinity Extends to Oct 2025. Bowen Acquisition (BOWN) Forward Purchase Agreement. 

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.